Stock vs Stock Comparison

Adaptive Biotechnologies Corporation vs Abbott Laboratories

ABT wins the Tale of the Tape 6–3.

ADPT$15.99
ABT$86.99

🏆 Tale of the Tape

36
ADPTABT
-21.5%Profitability (Net Margin)14.7%
Valuation (P/E)24.0x
-8.9%Efficiency (ROIC)10.1%
6/9Health (Piotroski F)5/9
1.1Safety (Altman Z)4.9
54.8%Growth (Rev YoY)5.7%
1.00Risk (Sharpe 1Y)-1.05
1.28xBalance Sheet (D/E)0.64x
-2.49%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.079
252-Day Correlation
-0.020
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricADPTABT
Market Cap$2.4B$149.1B
P/E Ratio24.0x
Forward P/E-58.9x14.1x
P/B11.18x2.86x
Dividend Yield2.94%
Beta2.160.65

Quantitative Metrics

MetricADPTABT
DCF Fair Value$57.20
DCF Upside-43.2%
Piotroski F6/95/9
Altman Z1.114.87
Beneish M-2.39-2.53
FCF Yield-2.49%4.21%
Net Debt/EBITDA0.1x
ROIC-8.9%10.1%
WACC18.3%9.4%
ROIC – WACC-27.2pp0.7pp
Gross Margin74.2%56.4%
Net Margin-21.5%14.7%
Rev Growth YoY54.8%5.7%
Sharpe (1Y)1.00-1.05
Max Drawdown 3Y-73.4%
FCF Payout Ratio56%

ADPT Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

ADPT found in:

ARKG2.24%
VFMO0.12%
VTWO0.06%
VBK0.03%
VHT0.03%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ADPT vs ABT: Head-to-Head Analysis

Adaptive Biotechnologies Corporation (ADPT) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ADPT generates a return on invested capital (ROIC) of -8.9% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ADPT and ABT is 0.079, indicating low correlation, making them an effective diversification pair in a portfolio context.

ADPT appears in 5 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ADPT or ABT?

Our quantitative analysis compares ADPT and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ADPT and ABT correlated?

The 252-day correlation between ADPT and ABT is 0.079. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.